Last reviewed · How we verify
Evaluation of the Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Versus Placebo in Patients With Adenoviral Conjunctivis (Goldeneye)
This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in decreasing the number of days where adenoviral conjunctivis is detected in the eye and in reducing the duration and/or the severity of the signs and symptoms of adenoviral conjunctivis
Details
| Lead sponsor | NicOx |
|---|---|
| Phase | Phase 2 |
| Status | WITHDRAWN |
| Start date | 2017-01 |
| Completion | 2017-09 |
Conditions
- Adenoviral Conjunctivitis
Interventions
- Iota-Carrageenan
- Carmellose
Primary outcomes
- Viral eradication time NCX 4240 versus Placebo — 21 days
Comparison in time to viral eradication in NCX-4240 and the placebo groups (when virus load is 0 or BLD - below the limit of detection) from the tears as measured by Polymerase Chain Reaction (PCR) at each visit.
Countries
Spain